Eigentler TK - Search Results

1

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.

Heppt MV, Heinzerling L, Kähler KC, Forschner A, Kirchberger MC, Loquai C, Meissner M, Meier F, Terheyden P, Schell B, Herbst R, Göppner D, Kiecker F, Rafei-Shamsabadi D, Haferkamp S, Huber MA, Utikal J, Ziemer M, Bumeder I, Pfeiffer C, Schäd SG, Schmid-Tannwald C, Tietze JK, Eigentler TK, Berking C. Heppt MV, et al. Among authors: eigentler tk. Eur J Cancer. 2017 Sep;82:56-65. doi: 10.1016/j.ejca.2017.05.038. Epub 2017 Jun 22. Eur J Cancer. 2017. PMID: 28648699

2

Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma.

Müller-Horvat C, Radny P, Eigentler TK, Schäfer J, Pfannenberg C, Horger M, Khorchidi S, Nägele T, Garbe C, Claussen CD, Schlemmer HP. Müller-Horvat C, et al. Among authors: eigentler tk. Eur J Cancer. 2006 Feb;42(3):342-50. doi: 10.1016/j.ejca.2005.10.008. Epub 2005 Dec 20. Eur J Cancer. 2006. PMID: 16364631

3

Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed?

Lasithiotakis KG, Leiter U, Eigentler T, Breuninger H, Metzler G, Meier F, Garbe C. Lasithiotakis KG, et al. Cancer. 2007 Mar 15;109(6):1174-82. doi: 10.1002/cncr.22511. Cancer. 2007. PMID: 17265520 Free article.

4

Age and gender are significant independent predictors of survival in primary cutaneous melanoma.

Lasithiotakis K, Leiter U, Meier F, Eigentler T, Metzler G, Moehrle M, Breuninger H, Garbe C. Lasithiotakis K, et al. Cancer. 2008 Apr 15;112(8):1795-804. doi: 10.1002/cncr.23359. Cancer. 2008. PMID: 18306371 Free article.

5

Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma.

Hauschild A, Trefzer U, Garbe C, Kaehler KC, Ugurel S, Kiecker F, Eigentler T, Krissel H, Schott A, Schadendorf D. Hauschild A, et al. Melanoma Res. 2008 Aug;18(4):274-8. doi: 10.1097/CMR.0b013e328307c248. Melanoma Res. 2008. PMID: 18626312 Clinical Trial.

6

Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients.

Meier F, Guenova E, Clasen S, Eigentler T, Forschner A, Leiter U, Zielinski C, Knaudt B, Garbe C, Berneburg M. Meier F, et al. J Am Acad Dermatol. 2009 May;60(5):863-8. doi: 10.1016/j.jaad.2008.09.053. J Am Acad Dermatol. 2009. PMID: 19389529

7

Costs of the detection of metastases and follow-up examinations in cutaneous melanoma.

Leiter U, Marghoob AA, Lasithiotakis K, Eigentler TK, Meier F, Meisner C, Garbe C. Leiter U, et al. Among authors: eigentler tk. Melanoma Res. 2009 Feb;19(1):50-7. doi: 10.1097/CMR.0b013e32831bc41c. Melanoma Res. 2009. PMID: 19430406

8

Clinical course and prognostic factors of Merkel cell carcinoma of the skin.

Güler-Nizam E, Leiter U, Metzler G, Breuninger H, Garbe C, Eigentler TK. Güler-Nizam E, et al. Among authors: eigentler tk. Br J Dermatol. 2009 Jul;161(1):90-4. doi: 10.1111/j.1365-2133.2009.09155.x. Epub 2009 Apr 29. Br J Dermatol. 2009. PMID: 19438439

9

Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement.

Leiter U, Buettner PG, Bohnenberger K, Eigentler T, Meier F, Moehrle M, Breuninger H, Garbe C. Leiter U, et al. Ann Surg Oncol. 2010 Jan;17(1):129-37. doi: 10.1245/s10434-009-0780-2. Epub 2009 Oct 29. Ann Surg Oncol. 2010. PMID: 19866238

10

Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial.

Hauschild A, Weichenthal M, Rass K, Linse R, Berking C, Böttjer J, Vogt T, Spieth K, Eigentler T, Brockmeyer NH, Stein A, Näher H, Schadendorf D, Mohr P, Kaatz M, Tronnier M, Hein R, Schuler G, Egberts F, Garbe C. Hauschild A, et al. J Clin Oncol. 2010 Feb 10;28(5):841-6. doi: 10.1200/JCO.2009.23.1704. Epub 2010 Jan 4. J Clin Oncol. 2010. PMID: 20048184 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

266 results

Search Page